Association of K-ras mutations with liver metastases from colorectal carcinoma

Anticancer Research

Volumn 24, Issue 4, 2004, Pages 2471-2476

  Tsunoda, Akira ^a   Iijima, Takeru ^b   Tsunoda, Yuko ^a   Nakao, Kentaroh ^a   Miyaki, Michiko ^c   Kusano, Mitsuo ^a  

^a SHOWA UNIVERSITY   (Japan)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

Colorectal carcinoma; K ras mutation; Liver metastases

Indexed keywords

ADULT; AGED; ARTICLE; CODON; COLORECTAL CARCINOMA; CORRELATION ANALYSIS; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; ONCOGENE K RAS; POINT MUTATION; PREDICTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; GENES, RAS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POINT MUTATION; PREDICTIVE VALUE OF TESTS;

EID: 4444269489     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Steele G and Ravikumar TS: Resection of hepatic metastases from colorectal colorectal carcinoma: biologic perspectives. Ann Surg 210: 127-38, 1989.
2. Hughes KS, Rosenstein RB, Songhorabodi S et al: Resection of the liver for colorectal carcinoma metastases: a multiinstitutional study of long term survivors. Dis Colon Rectum 31: 1-4, 1988.
3. Wagner JS, Adson MA, van Heerden JA, Adson MH and Ilstrup DM: The natural history of hepatic metastases from colorectal cancer: a comparison with resective rearment. Ann Surg 199: 502-8, 1984.
4. Gilbert HA and Kagan AR: Metastases: incidence, detection, and evaluation without histologic confirmation. In: Weiss L, ed. Holland 385-405, 1976.
5. Bos JL, Fearon ER, Hamilton SR et al: Prevalence of ras gene mutations in human colorectal cancers. Nature 327: 293-7, 1987.
6. Forrester K, Almoguera C, Han K, Grizzle WE and Perucho M: Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 327: 298-303, 1987.
7. Vogelstein B, Fearon ER, Hamilton SR et al: Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-32, 1988.
8. McLellan EA, Owen RA, Stepniewska KA, Sheffield JP and Lemoine NR: High frequency of K-ras mutations in sporadic colorectal adenomas. Gut 34: 392-6, 1993.
9. Finkelstein SD, Sayegh R, Bakker A and Swalsky P: Determination of tumor aggressiveness in colorectal cancer by K-ras-2 analysis. Arch Surg 128: 526-32, 1993.
10. Benhattar J, Losi L, Chaubert P, Givel J and Costa J: Prognostic significance of K-ras mutations in colorectal carcinoma. Gastroenterology 104: 1044-8, 1993.
11. Andersen SN, Løvig T, Breivik J et al: K-ras mutations and prognosis in large-bowel carcinomas. Scand J Gastroenterol 32: 62-9, 1997.
12. Kastrinakis WV, Ramchurren N, Maggard M, Steele G and Summerhayes IC: K-ras status does not predict successful hepatic resection of colorectal cancer metastasis. Arch Surg 130: 9-14, 1995.
13. Shimanski CC, Linnemann U and Berger MR: Sensitive detection of K-ras mutations augments diagnosis of colorectal cancer metastases in the liver. Cancer Res 59: 5169-75, 1999.
14. Schimanski CC, Linnemann U, Arbogast R and Berger M: Extended staging results from the detection of isolated tumor cells in the liver of colorectal cancer patients. Oncology Reports 8: 185-8, 2001.
15. Nakao K, Shibusawa M, Ishihara A et al: Gene changes in colorectal carcinoma tumors with liver metastases analyzed by comparative genomic hybridization and DNA ploidy. Cancer 91: 721-6, 2001.
16. Miyaki M, Konishi M, Kikuchi-Yanoshita R et al: Characteristics of somatic mutation of adenomatous polyposis coli gene in colorectal tumors. Cancer Res 54: 3011-20, 1994.
17. Orita M, Suzuki Y, Sekiya T and Hayashi K: Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5: 874-9, 1989.
18. Suzuki Y, Sekiya T and Hayashi K: Allele-specific polymerase chain reaction: a method for amplification and sequence determination of a single component among a mixture of sequence variants. Anal Biochem 192: 82-4, 1991.
19. Casanova JL, Pannetier C, Jaulin C and Kourilsky P: Optimal conditions for directly sequencing double-stranded PCR products with sequenase. Nucl Acid Res 18: 4028-9, 1990.
20. Burmer GC, Rabinovitch PS and Loeb LA: Frequency and spectrum of c-Ki-ras mutations in human sporadic colon carcinoma, carcinomas arising in ulcerative colitis and pancreatic adenocarcinoma. Environ Health Perspect 93: 27-31, 1991.
21. Ahnen DJ, Feigl P, Quan G et al: Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study. Cancer Res 58: 1149-58, 1998.
22. Bennett MA, Kay EW, Mulcahy H et al: Ras and p53 in the prediction of survival in Dukes' stage B colorectal carcinoma. J Clin Pathol 48: M310-M315, 1995.
23. Bouzourene H, Gervaz P, Cerottini J-P et al: P53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer. Eur J Cancer 36: 1008-15, 2000.
24. Carter R, Hemingway D, Cooke TG et al. A prospective study of six methods for detection of hepatic colorectal metastases. Ann R Coll Surg Engl 78: 27-30, 1996.
25. Vassiliades VG, Foley WD, Alarcon J et al: Hepatic metastases: CT versus MR imaging at 1.5 T. Gastrointest Radiol 16: 159-63, 1991.
26. Shibata D, Schaeffer J, Li ZH, Capella G and Perucho M: Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas. J Natl Cancer Inst 85: 1058-63, 1993.
27. Moerkerk P, Arends JW, van Driel M et al: Type and number of Ki-ras point mutations relate to stage of human colorectal cancer. Cancer Res 54: 3376-8, 1994.